Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study.
about
Ribavirin plus interferon versus interferon for chronic hepatitis CThe accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational studyNon-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Four-week pegylated interferon a-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized studyMechanisms and significance of liver steatosis in hepatitis C virus infectionTwice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapyPeginterferon and ribavirin treatment for hepatitis C virus infectionChanges in lipid metabolism in chronic hepatitis C.Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis CPharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN alpha-2a (40KD) (PEGASYS).Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin.Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD).Commentary on: The optimal Dose of Ribavirin for Chronic Hepatitis C: From Literature Evidence to Clinical Practice.HCV treatment uptake in people who have injected drugs - observations in a large cohort that received addiction treatment 1970-1984.Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection.Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study.Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response.Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin.A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naïve patients with chronic hepatitis C.High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy.Hepatitis C virus RNA levels during initial induction or standard interferon therapy: influence of continued treatment on sustained response.Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia.Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.Potent induction therapy with interferon and ribavirin combination therapy does not achieve a higher sustained virological response rate in chronic hepatitis C with genotype 1b and high hepatitis C virus RNA level.Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin.Scandinavian Journal of Gastroenterology - the editors-in-chief.Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine.
P2860
Q24240879-4B99997C-2587-4CEA-A2D7-704B7CB2055BQ24794434-9D76A488-688A-49C9-9D36-7B1AB0484E31Q27478313-ED4684D6-689A-47C0-84BF-1D57CDF51E4FQ27478329-88AA480E-7FAD-4473-B289-A4968E9F51EEQ27490396-76B9F5FF-F79D-4416-A1E1-33F6A49AC4DDQ33866272-5E763233-5C04-4A59-BAE1-F4CB0B7C72D8Q33924165-10CFFE67-65F7-4D15-A6EF-62648DFC2E6FQ34521371-627363DA-CF03-4CD8-A11C-1556AE29CE89Q35165949-D72B2A4A-D433-4CDD-B0A0-2F9884B056E1Q37133483-CCB24FF5-B3FC-4EB7-95D5-75A3A578CA80Q37173940-5EFEA589-1160-4B1B-9DB0-FD445FA18029Q38997352-BB5D697A-BA46-4EF6-BFC0-B24744C69AD8Q39371640-EB180A91-239D-48F5-BFDE-155FEA350370Q39974107-50528DDC-1D4E-4BF7-8BE1-73142003C5FDQ41703740-ABDB76CC-5719-4E20-AA85-D7491B5EF55BQ42982615-0DA5F753-4EA4-41F5-A1D2-2B73D5D1E74AQ42989003-0D914681-B351-432B-B5F7-1FBD6BCA69E7Q42990123-93E713A7-66B5-485D-B76D-07FBFDB2D056Q42992776-2A0DB98C-74EF-44C4-A2B2-C4C6C0B47319Q42994528-2881B10F-5C75-473C-907D-401414E05E23Q43032258-2BCAA91C-14F4-48CF-A7A9-B1DF369FE5F0Q43038897-00437BE8-AD2D-416E-A93F-300967F69022Q43046523-1C1AE470-F3AE-438A-9969-9E2FAB8B0619Q43048552-BE190376-2B2B-4BC6-9995-048D47223FBBQ43048580-72608DED-B0B2-4129-B146-7239D38B3CC1Q43049327-C5E7BB38-12B6-4E8F-96B6-F6857B6B39C1Q43975469-056E27CD-DA8C-4272-B2CE-98CB2F0DE077Q45402889-7CB55D74-0CB9-4DDE-8B80-B1B1675805C0Q46789982-08AD3F9E-30A3-414C-8B14-8986668EA611Q48044503-7B094EF9-6AD9-422C-B2BB-BC37D2B4ED16Q50580456-C9FBB57F-B1BF-4FA5-AF1B-A6F3C5784E2F
P2860
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Effect of combined interferon- ...... randomized multicentre study.
@en
Effect of combined interferon- ...... randomized multicentre study.
@nl
type
label
Effect of combined interferon- ...... randomized multicentre study.
@en
Effect of combined interferon- ...... randomized multicentre study.
@nl
prefLabel
Effect of combined interferon- ...... randomized multicentre study.
@en
Effect of combined interferon- ...... randomized multicentre study.
@nl
P2093
P1476
Effect of combined interferon- ...... randomized multicentre study.
@en
P2093
B Døskeland
K B Hellum
N Raknerud
S Lund-Tønnesen
P304
P356
10.1080/003655202753416920
P577
2002-02-01T00:00:00Z